Hosted on MSN1mon
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
Axios Vitals on MSN3mon
FDA halts trial of Novavax COVID-flu combo shot
The clinical hold does not impact Novavax's COVID-19 vaccine. The big picture: Pfizer and BioNTech's effort to develop a ...
Nasdaq1mon
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s ... COVID/flu combination vaccines. Earlier today, SNY announced that the FDA ...
Seeking Alpha5d
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade)
I have been warning about Novavax's risks since 2016, highlighting its ongoing struggles with the FDA. Novavax's Q3 ... Novavax's combination proprietary flu plus COVID combo "very, very soon ...
Nasdaq1mon
FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates
SNY markets Fluzone High-Dose and Flublok flu vaccines. Novavax recently signed a multi-billion dollar deal with Sanofi for its protein-based COVID ... (Hold). You can see the complete list of ...